相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Typical and Atypical Hemolytic Uremic Syndrome in the Critically Ill
Carlos L. Manrique-Caballero et al.
CRITICAL CARE CLINICS (2020)
Shiga Toxin-Associated Hemolytic Uremic Syndrome: A Narrative Review
Adrien Joseph et al.
TOXINS (2020)
Shiga-Toxin E. coli Hemolytic Uremic Syndrome: Review of Management and Long-term Outcome
V. J. Harkins et al.
CURRENT PEDIATRICS REPORTS (2020)
Extrarenal manifestations of the hemolytic uremic syndrome associated with Shiga toxin-producing Escherichia coli (STEC HUS)
Myda Khalid et al.
PEDIATRIC NEPHROLOGY (2019)
Complement Activation Contributes to the Pathophysiology of Shiga Toxin-Associated Hemolytic Uremic Syndrome
Simona Buelli et al.
MICROORGANISMS (2019)
Hemolytic uremic syndrome due to Shiga toxin-producing Escherichia coli infection
M. Bruyand et al.
MEDECINE ET MALADIES INFECTIEUSES (2018)
Enterohaemorrhagic and other Shiga toxin-producing Escherichia coli (STEC): Where are we now regarding diagnostics and control strategies?
D. G. Newell et al.
TRANSBOUNDARY AND EMERGING DISEASES (2018)
Non-O157 Shiga toxin-producing Escherichia coli-A poorly appreciated enteric pathogen: Systematic review
Evangelia Valilis et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2018)
Associations Between Hydration Status, Intravenous Fluid Administration, and Outcomes of Patients Infected With Shiga Toxin-Producing Escherichia coli A Systematic Review and Meta-analysis
Silviu Grisaru et al.
JAMA PEDIATRICS (2017)
Clinical characteristics and long-term outcome of diarrhea-associated hemolytic uremic syndrome: a single center experience
Takeshi Ninchoji et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2017)
Shiga Toxin-Producing Escherichia coli Infection, Antibiotics, and Risk of Developing Hemolytic Uremic Syndrome: A Meta-analysis
Stephen B. Freedman et al.
CLINICAL INFECTIOUS DISEASES (2016)
Pseudomembranous colitis
Priya D. Farooq et al.
DM DISEASE-A-MONTH (2015)
ACG Clinical Guideline: Epidemiology, Risk Factors, Patterns of Presentation, Diagnosis, and Management of Colon Ischemia (CI)
Lawrence J. Brandt et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2015)
Laboratory predictors of acute dialysis in hemolytic uremic syndrome
Alejandro Balestracci et al.
PEDIATRICS INTERNATIONAL (2014)
Clinical Features of Critically Ill Patients With Shiga Toxin-Induced Hemolytic Uremic Syndrome
Stephan A. Braune et al.
CRITICAL CARE MEDICINE (2013)
Increased Recognition of Non-O157 Shiga Toxin-Producing Escherichia coli Infections in the United States During 2000-2010: Epidemiologic Features and Comparison with E. coli O157 Infections
L. Hannah Gould et al.
FOODBORNE PATHOGENS AND DISEASE (2013)
Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic-Uremic Syndrome
C. M. Legendre et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Vergleich von CD38-spezifischen Nanobodies und konventionellen Antikörpern für die Nah-Infrarot-Fluoreszenz Bildgebung von Lymphomen in vivo
P Bannas et al.
ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN (2013)
Need for Long-term Follow-up in Enterohemorrhagic Escherichia coli-Associated Hemolytic Uremic Syndrome Due to Late-Emerging Sequelae
Alejandra Rosales et al.
CLINICAL INFECTIOUS DISEASES (2012)
Renal and neurological involvement in typical Shiga toxin-associated HUS
Howard Trachtman et al.
NATURE REVIEWS NEPHROLOGY (2012)
Hemorrhagic colitis in postdiarrheal hemolytic uremic syndrome: retrospective analysis of 54 children
Ricardo C. Rahman et al.
PEDIATRIC NEPHROLOGY (2012)
Eculizumab in Severe Shiga-Toxin-Associated HUS
Anne-Laure Lapeyraque et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Acute Neurological Involvement in Diarrhea-Associated Hemolytic Uremic Syndrome
Sylvie Nathanson et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Hemolytic Uremic Syndrome and Death in Persons with Escherichia coli O157:H7 Infection, Foodborne Diseases Active Surveillance Network Sites, 2000-2006
L. Hannah Gould et al.
CLINICAL INFECTIOUS DISEASES (2009)